S&P CLINICAL RESEARCH ORGANISATION


Clinical Trials in Eastern Europe allow faster approval
processes and patient recruitment rates than in
Western countries.

In 2003, Western European Clinical Trials sourced
25-50% of patients from Eastern Europe

S&P is the longest established CRO operating in Eastern Europe

S&P cuts through logistical and communication issuses that 
act as barriers to the Eastern European patient population


S&Pīs clients source 70-100% of patients from Eastern Europe.
Drug Development time ist cut by 50-60%